| NCT ID | NCT03807687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliera Universitaria Integrata Verona |
| Condition | Pancreatic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2016-12-01 |
| Primary Completion | 2046-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2016-12-01 with a primary completion date of 2046-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.
Eligibility Criteria
Inclusion Criteria: * any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions) Exclusion Criteria: * physically or mentally inability to provide consent
Contact & Investigator
Claudio Bassi, Prof
PRINCIPAL INVESTIGATOR
AOUI Verona
Frequently Asked Questions
Who can join the NCT03807687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03807687 currently recruiting?
Yes, NCT03807687 is actively recruiting participants. Contact the research team at erica.secchettin@aovr.veneto.it for enrollment information.
Where is the NCT03807687 trial being conducted?
This trial is being conducted at Verona, Italy.
Who is sponsoring the NCT03807687 clinical trial?
NCT03807687 is sponsored by Azienda Ospedaliera Universitaria Integrata Verona. The principal investigator is Claudio Bassi, Prof at AOUI Verona. The trial plans to enroll 3,000 participants.